Cite
HARVARD Citation
Macbeth, F. et al. (2021). Should We be Offering our Patients with Oligometastases Stereotactic Ablative Body Radiotherapy – No. Clinical oncology. 33 (12), pp. 749-750. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Macbeth, F. et al. (2021). Should We be Offering our Patients with Oligometastases Stereotactic Ablative Body Radiotherapy – No. Clinical oncology. 33 (12), pp. 749-750. [Online].